Top Sector Life Sciences & Health Activities in 2015

Top Sector Life Sciences & Health had a busy year with a wide variety of activities. This overview illustrates Top Sector LSH's main accomplishments in 2015.

This year started with some changes in the team. First of all Nico van Meeteren was welcomed as the new executive director. Shortly afterwards Jan Raaijmakers became the new chairman of the Top Sector LSH. In addition, all communication activities now occur under the name of Health~Holland.

During 2015 the following activities were realised. 


Startups & New Ventures:

4 Strategic Documents

Coalition formation with fellow Dutch Top Sectors

​Buildup of Financial
potential of LSH 

TKI Allowance 

For more information on the TKI visit the Health~Holland website

Value Centre

A new joint activity between LS@W and Medtech Partners is the recently launched Value Centre. In the Value Centre startups with growth ambitions can apply for a voucher of 10,000 euros to hire specialist advice to enable them to speed up their market introduction. All innovators that need help from a third party to further develop their product or business case can pursue the voucher, with the exception of production related questions. Currently, four entrepreneurs have successfully been helped by a voucher in 2015 (Inreda, Tide Microfluedics, Quirem Medical and Novuqare) and several requests are in progress.

New partnership

Towards the end of 2015 Loyens & Loeff joined LS@W as a partner bringing their expertise and experience in legal affairs and tax. Life Sciences startups are mostly active in an international context and handle highly sensitive personal health information. Having a legal and tax partner on board that is familiar with the sector and internationally focused is particularly useful. Loyens & Loeff has the experience and know-how required to help LS@W startups prepare for their international endeavours. For further information please visit the website.

Successes of LS@W startups in 2015

  • Kite Pharma acquired T-Cell factory
  • Nightbalance’s sleep position trainer reimbursed
  • Cristal Therapeutics started Phase I trails
  • Oncodrone received a Eurostars Grant worth 2.5 million euros
  • Nutrileads closed a seed financing round
  • Ocello announced a strategic partnership with Synthon
  • InteRNA Technologies closed a 10.5 million dollar series 
  • Mimetas and partners received 1.6 million euros in industry funding
  • Toxys won the Biobusiness Masterclass
  • Khondrion reported successful outcome phase I clinical trails
  • Quirem medical received investment Terumo